Novacap strengthens its Cosmetics and Healthcare offering with the acquisition of ID bio.

COMPLETION OF THE STRATEGIC COMBINATION BETWEEN NOVACAP AND PCAS

Novacap strengthens its Cosmetics and Healthcare offering with the acquisition of ID bio, a manufacturer of botanical ingredients and H2B, a manufacturer of ingredients for in vitro diagnosis.

 

Novacap, a worldwide player in the pharmaceutical and cosmetics industry, announced that it has acquired ID bio, a producer of natural ingredients for cosmetics, along with H2B, a manufacturer of fractionated blood products for in vitro diagnosis.
Novacap serves the cosmetics industry with essential ingredients used as preservatives, UV filters, exfoliants and fragrances. ID bio leverages its expertise in enzymatic extraction and purification to develop innovative active ingredients and botanical extracts. ID bio focuses on ethical and eco-friendly sourcing of raw materials to offer differentiated ingredients with controlled traceability.
The acquisition of ID bio by Novacap meets the group’s growth strategy which aims at supplying its clients with a wide range of active and functional ingredients and widening its cosmetic portfolio with natural products.
In addition, H2B will strengthen Novacap’s positioning on the Pharmaceutical and Healthcare markets.
“ID bio and H2B’s innovation capabilities will enrich Novacap’s offering and ability to meet the needs of our customers”, stated Pierre Luzeau, Novacap CEO.
“Novacap will support ID bio and H2B to accelerate their development leveraging the two companies’ market approaches and recognised expertise. The complementarities between our two groups open up outstanding prospects for the future”, said Jean-Pierre Picot, Founding President of ID bio.
ID bio and H2B will benefit from Novacap’s industrial and regulatory expertise and large client portfolio to accelerate their growth.

About ID bio & H2B

ID bio is a biotechnology firm, specialising since 1993 in the extraction, fractionation and purification of botanical substances for the cosmetics industry. This core know-how allows the company to offer botanical ingredients developed with rigorous procedures. ID bio offers a large range of botanical extracts, titrated extracts and active ingredients with applications in hair, make-up and care products.
H2B is specialised in the manufacturing of fractionated blood products for in vitro diagnosis. With over 20 years of experience, the firm has become an expert in fractionation, extraction and purification of animal and human proteins. H2B has developed two different product ranges from bovine plasma and, since 2009, from human plasma so as to meet new market expectations.
ID bio and H2B have also been awarded ISO 9001 and ISO 14001 certifications for their commitment to quality – security – environment culture.

Download the press release